论文部分内容阅读
腹腔化疗是治疗晚期消化道肿瘤的一种重要方法,过去认为只能消退癌性腹水,近来认为有全身化疗的作用。因此,自从1993年起,我们在腹腔化疗治疗晚期胃癌时,同时观察了癌性腹水和肝转移癌的治疗效果,现报告如下。 临床资料 1.对象:26例同时伴有癌性腹水和肝转移的晚期胃癌病人,均经手术切除证实并复发,复发时间为手术后2个月～2年,平均9.3个月。其中男性10例,女性16例,年龄35～67岁,平
Intraperitoneal chemotherapy is an important method for the treatment of advanced digestive tract tumors. In the past, it was thought that only cancerous ascites could be regressed. Recently, systemic chemotherapy was considered effective. Therefore, since 1993, we have observed the therapeutic effects of cancerous ascites and liver metastases in the treatment of advanced gastric cancer by intraperitoneal chemotherapy. The report is as follows. Clinical data 1.Objectives: Twenty-six cases of advanced gastric cancer patients with cancerous ascites and liver metastases were confirmed by surgical resection and recurrence. The recurrence time was 2 months to 2 years after surgery, with an average of 9.3 months. Among them, there are 10 males and 16 females, aged 35 to 67 years old.